Risk assessment of obstructive sleep apnea syndrome in pediatric patients with vitamin D deficiency: A questionnaire-based study.
The aim of the following study is to evaluate the risk of obstructive sleep apnea syndrome (OSAS) in subjects with vitamin D deficiency.Prospective and comparative study.We enrolled 240 subjects into the study. The participants were divided into 2 groups based on 25-hydroxyvitamin D (25[OH]D) levels: low level of 25(OH)D (<20 ng/mL) group (n = 120) and control (>20 ng/mL) group (n = 120). Subjects were classified as being at a high or low risk of developing OSAS by using the Berlin Questionnaire. Risk of developing OSAS, gender, age, and body mass index (BMI) z-score were assessed by comparing the low level of 25(OH)D group and control group.No statistically significant difference was observed between the low level of 25(OH)D group and control group in terms of gender, age, and BMI z-score distributions; P = 0.323, P = 0.387, and P = 0.093, respectively. There were 24 subjects with high risk of developing OSAS in 2 groups (17 subjects in the low level of 25[OH]D group and 7 subjects in the control group). In the low level of 25(OH)D group, the risk of developing OSAS was found to be significantly higher than the control group (P = 0.030). BMI z-score was found significantly higher in high-risk groups than low-risk groups (P = 0.034 for low-level 25[OH]D group and P = 0.023 for control group).The findings revealed that low level of 25(OH)D increases the risk of developing OSAS.
aDepartment of Pediatrics, Suleymaniye Maternity and Children's Training and Research Hospital bDepartment of Pediatrics, Bezmialem Vakıf University, Faculty of Medicine, İstanbul, Turkey.
Gamze
G
Ozgurhan
Aysel
A
Vehapoglu
Oznur
O
Vermezoglu
Rabia Nur
RN
Temiz
Asuman
A
Guney
Bulent
B
Hacihamdioglu
D000293:Adolescent; D000367:Age Factors; D015992:Body Mass Index; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D017286:Polysomnography; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D012737:Sex Factors; D020181:Sleep Apnea, Obstructive / Q000453:epidemiology*; D014807:Vitamin D / Q000031:analogs & derivatives / Q000097:blood; D014808:Vitamin D Deficiency / Q000453:epidemiology*
D014807:Vitamin D; C104450:25-hydroxyvitamin D
J Endocrinol Invest. 2013 Oct;36(9):681-5
23558409
Sleep. 2012 May 01;35(5):605-15
22547886
Pediatr Endocrinol Rev. 2011 Sep;9(1):456-62
22783643
Am J Respir Crit Care Med. 2005 Dec 15;172(12):1590-5
16192452
Pediatrics. 2012 Sep;130(3):e714-55
22926176
N Engl J Med. 2007 Jul 19;357(3):266-81
17634462
Diabetes Care. 2008 May;31(5):1001-6
18268072
Endocrine. 2014 Mar;45(2):311-8
23904340
Am J Epidemiol. 2001 Jul 1;154(1):50-9
11434366
Sleep Med. 2014 Apr;15(4):459-63
24684979
Endocrinol Metab Clin North Am. 2003 Dec;32(4):869-94
14711066
Intern Emerg Med. 2013 Feb;8(1):33-40
21437585
Pediatr Pulmonol. 2011 Apr;46(4):313-23
20967842
Int J Obes (Lond). 2014 Jan;38(1):46-52
23736361
J Clin Endocrinol Metab. 2012 Jan;97(1):279-85
22072738
Am J Respir Crit Care Med. 2002 May 1;165(9):1217-39
11991871
J Pediatr Endocrinol Metab. 2013;26(1-2):97-104
23382301
Sleep Med Rev. 2014 Aug;18(4):311-9
24075129
Sleep. 2016 Feb 01;39(2):293-300
26414899
Eur J Endocrinol. 2011 Oct;165(4):603-11
21753070
J Clin Exp Neuropsychol. 2004 Feb;26(1):43-54
14972693
J Clin Endocrinol Metab. 2010 Sep;95(9):4220-2
20823471
JAMA. 2000 Apr 12;283(14):1829-36
10770144
Int J Pediatr Otorhinolaryngol. 2011 Feb;75(2):261-4
21131064
Arch Dis Child. 2011 May;96(5):447-52
21335626
Ann N Y Acad Sci. 2007 Nov;1117:94-105
17656563
Diabetes Care. 2010 Jun;33(6):1373-5
20332348
Pediatrics. 2013 Jan;131(1):e152-61
23266927
Endocr Rev. 2012 Jun;33(3):456-92
22596255
Endocrine. 2012 Jun;41(3):518-25
22246808
Clin Exp Immunol. 2011 Apr;164(1):72-9
21323660
Front Biosci (Elite Ed). 2012 Jun 01;4:2410-22
22652648
Diabetes Care. 2010 Jun;33(6):1379-81
20215450
Clin Infect Dis. 2013 Aug;57(3):392-7
23677871